Todd Druley

Medicine & Life Sciences

1. Mutation 100%
2. Genes 64%
3. Leukemia 60%
4. Hematopoiesis 54%
5. Exome 51%
6. ATP Binding Cassette Transporter, Subfamily B, Member 1 49%
7. High-Throughput Nucleotide Sequencing 45%
8. Pediatrics 42%
9. Hematopoietic Stem Cells 39%
10. Acute Myeloid Leukemia 37%
11. Single Nucleotide Polymorphism 35%
12. Neoplasms 35%
13. Child 33%
14. Newborn Respiratory Distress Syndrome 30%
15. Genome 30%
16. Hematologic Neoplasms 30%
17. Nucleotides 28%
18. Neurofibromatosis 1 27%
19. Whole Exome Sequencing 26%
20. RNA Sequence Analysis 26%
21. DNA 24%
22. Alleles 24%
23. Distal type 1 Arthrogryposis multiplex congenita 24%
24. Genetic Variation 23%
25. Residual Neoplasm 23%
26. Heterografts 23%
27. Clone Cells 23%
28. Zebrafish 22%
29. Adenosine Triphosphate 22%
30. DNA Sequence Analysis 21%
31. Herbaspirillum 21%
32. Isolated Hemihyperplasia 21%
33. Phenotype 20%
34. Chromosome Duplication 20%
35. Hematopoietic Stem Cell Transplantation 19%
36. Transplants 19%
37. Costs and Cost Analysis 19%
38. Type 1 Autoimmune polyendocrinopathy syndrome 18%
39. Mesoderm 18%
40. Hemangioblasts 17%
41. Ciliary Motility Disorders 16%
42. Telomere 16%
43. Tissue Donors 16%
44. Serum Response Factor 16%
45. Dominant Genes 15%
46. Bacterial Artificial Chromosomes 15%
47. Precursor Cell Lymphoblastic Leukemia-Lymphoma 15%
48. Hepatoblastoma 15%
49. Pedigree 15%
50. Limit of Detection 14%